Corneal Endothelium Morphology and Central Thickness in Type II Diabetes Mellitus and Normal Subjects
NCT ID: NCT01084850
Last Updated: 2010-03-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2009-06-30
2010-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Corneal Endothelial Changes Associated With Phacoemulsification in Diabetes Mellitus Type II
NCT01078103
Evaluation of Corneal Confocal Microscopy for the Identification and Prediction of Neuropathy in Type 1 Diabetes
NCT02423434
Study of the Impact of Cataract Surgery on the Corneal Epithelium and Ocular Surface of Diabetic Patients
NCT06638424
Corneal Endothelial Cell Loss in Diabetes Type II During Cataract Surgery
NCT00446277
CORNEAL EPITHELIAL MAPPING IN DIABETICS
NCT04734158
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diabetes Type II
Patients with type 2 Diabetes Mellitus
No interventions assigned to this group
Control
Patients with no diabetes
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Controls with no diabetes (confirmed by blood testing).
Exclusion Criteria
* Uveitis (current or previous)
* Corneal scaring
* Previous eye surgery
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Frederiksberg University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Frederiksberg Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jens C Norregaard, MD, phd
Role: STUDY_CHAIR
Frederiksberg University Hospital, Eye Clinque
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Frederiksberg University Eye Clinque
Frederiksberg, Frederiksberg, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FH5
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.